These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 16359169
1. Identification of N-(hydroxymethyl) norcotinine as a major product of cytochrome P450 2A6, but not cytochrome P450 2A13-catalyzed cotinine metabolism. Brown KM, von Weymarn LB, Murphy SE. Chem Res Toxicol; 2005 Dec; 18(12):1792-8. PubMed ID: 16359169 [Abstract] [Full Text] [Related]
2. Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism. Murphy SE, Johnson LM, Pullo DA. Chem Res Toxicol; 1999 Jul; 12(7):639-45. PubMed ID: 10409404 [Abstract] [Full Text] [Related]
3. N-glucuronidation of trans-3'-hydroxycotinine by human liver microsomes. Kuehl GE, Murphy SE. Chem Res Toxicol; 2003 Dec; 16(12):1502-6. PubMed ID: 14680362 [Abstract] [Full Text] [Related]
4. Trans-3'-hydroxycotinine O- and N-glucuronidations in human liver microsomes. Yamanaka H, Nakajima M, Katoh M, Kanoh A, Tamura O, Ishibashi H, Yokoi T. Drug Metab Dispos; 2005 Jan; 33(1):23-30. PubMed ID: 15470160 [Abstract] [Full Text] [Related]
5. Nicotine 5'-oxidation and methyl oxidation by P450 2A enzymes. Murphy SE, Raulinaitis V, Brown KM. Drug Metab Dispos; 2005 Aug; 33(8):1166-73. PubMed ID: 15860657 [Abstract] [Full Text] [Related]
6. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. Kim I, Darwin WD, Huestis MA. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan 25; 814(2):233-40. PubMed ID: 15639444 [Abstract] [Full Text] [Related]
7. Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. Crooks PA, Li M, Dwoskin LP. Drug Metab Dispos; 1997 Jan 25; 25(1):47-54. PubMed ID: 9010629 [Abstract] [Full Text] [Related]
8. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. J Pharmacol Exp Ther; 1996 May 25; 277(2):1010-5. PubMed ID: 8627511 [Abstract] [Full Text] [Related]
9. Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. Jacob P, Yu L, Duan M, Ramos L, Yturralde O, Benowitz NL. J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb 01; 879(3-4):267-76. PubMed ID: 21208832 [Abstract] [Full Text] [Related]
10. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3'-hydroxycotinine in smokers. Byrd GD, Chang KM, Greene JM, deBethizy JD. Drug Metab Dispos; 1992 Feb 01; 20(2):192-7. PubMed ID: 1352209 [Abstract] [Full Text] [Related]
11. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Hecht SS, Carmella SG, Murphy SE. Cancer Epidemiol Biomarkers Prev; 1999 Oct 01; 8(10):907-13. PubMed ID: 10548320 [Abstract] [Full Text] [Related]
12. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Avent KM, DeVoss JJ, Gillam EM. Chem Res Toxicol; 2006 Jul 01; 19(7):914-20. PubMed ID: 16841959 [Abstract] [Full Text] [Related]
13. Biotransformation of primary nicotine metabolites. II. Metabolism of [3H]-S-(-)-cotinine in the guinea pig: determination of in vivo urinary metabolites by high-performance liquid-radiochromatography. Cundy KC, Crooks PA. Xenobiotica; 1987 Jul 01; 17(7):785-92. PubMed ID: 3660848 [Abstract] [Full Text] [Related]
14. Female sex and oral contraceptive use accelerate nicotine metabolism. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P. Clin Pharmacol Ther; 2006 May 01; 79(5):480-8. PubMed ID: 16678549 [Abstract] [Full Text] [Related]
15. CYP2C19 Plays a Major Role in the Hepatic N-Oxidation of Cotinine. Perez-Paramo YX, Watson CJW, Chen G, Lazarus P. Drug Metab Dispos; 2023 Jan 01; 51(1):29-37. PubMed ID: 35197312 [Abstract] [Full Text] [Related]
16. [Concentration of cotinine and trans-3'-hydroxycotinine and its glucuronides in urine of smoking pregnant women]. Kedziora H, Florek E, Piekoszewski W, Breborowicz GH, Anholcer A, Gomółka E, Kulza M, Stanek A. Przegl Lek; 2007 Jan 01; 64(10):740-6. PubMed ID: 18409299 [Abstract] [Full Text] [Related]
17. Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells. Ljungberg LU, Persson K. Endothelium; 2008 Jan 01; 15(5-6):239-45. PubMed ID: 19065315 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of nicotine, cotinine, and 3'-hydroxycotinine in cigarette smokers. Scherer G, Jarczyk L, Heller WD, Biber A, Neurath GB, Adlkofer F. Klin Wochenschr; 1988 Jan 01; 66 Suppl 11():5-11. PubMed ID: 3184779 [Abstract] [Full Text] [Related]
19. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Dicke KE, Skrlin SM, Murphy SE. Drug Metab Dispos; 2005 Dec 01; 33(12):1760-4. PubMed ID: 16174803 [Abstract] [Full Text] [Related]
20. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. Clin Pharmacol Ther; 2006 Jun 01; 79(6):600-8. PubMed ID: 16765148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]